You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PALLADONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Palladone, and what generic alternatives are available?

Palladone is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in PALLADONE is hydromorphone hydrochloride. There are fourteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PALLADONE?
  • What are the global sales for PALLADONE?
  • What is Average Wholesale Price for PALLADONE?
Drug patent expirations by year for PALLADONE
Recent Clinical Trials for PALLADONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MiamiPhase 2

See all PALLADONE clinical trials

US Patents and Regulatory Information for PALLADONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-001 Sep 24, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-004 Sep 24, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-002 Sep 24, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-003 Sep 24, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PALLADONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-002 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-002 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-002 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-001 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-004 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-003 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
Purdue Pharma Lp PALLADONE hydromorphone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021044-004 Sep 24, 2004 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PALLADONE

See the table below for patents covering PALLADONE around the world.

Country Patent Number Title Estimated Expiration
Austria 212224 ⤷  Sign Up
Denmark 0699436 ⤷  Sign Up
Australia 6605894 ⤷  Sign Up
Czech Republic 284382 Pevná léková forma s řízeným uvolňováním účinné látky (SOLID MEDICAMENT FORM WITH CONTROLLED RELEASE OF ACTIVE COMPONENT) ⤷  Sign Up
Japan H07138189 RELEASE CONTROL PREPARATION COATED WITH ETHYL CELLULOSE AQUEOUS DISPERSION ⤷  Sign Up
Norway 331650 ⤷  Sign Up
Czech Republic 288517 Farmaceutický prostředek v jednotkové dávkovací formě a způsob jeho přípravy (Pharmaceutical preparation in unit dosage form and process of its preparation) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.